NCT05272462View on ClinicalTrials.gov

Oral Minoxidil for the Treatment of Recurrent Platinum Resistant Epithelial Ovarian Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

December 13, 2021

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Ovarian Cancer
Interventions
DRUG

Minoxidil

Minoxidil is an antihypertensive vasodilator medication commonly used for the treatment of high blood pressure and pattern hair loss.

Trial Locations (1)

60153

RECRUITING

Loyola University Medical Center, Maywood

All Listed Sponsors
collaborator

Cures Within Reach

OTHER

collaborator

Medical University of South Carolina

OTHER

lead

Loyola University

OTHER